4//SEC Filing
WOLLAEGER TIMOTHY J 4
Accession 0001005477-06-006087
CIK 0000707388other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 2:40 PM ET
Size
11.9 KB
Accession
0001005477-06-006087
Insider Transaction Report
Form 4
DIGIRAD CORPDRAD
WOLLAEGER TIMOTHY J
Director
Transactions
- Other
Common Stock
2006-12-26−339,766→ 0 total(indirect: By Kingsbury Capital Partners, L.P. IV) - Other
Common Stock
2006-12-26+19,887→ 132,792 total(indirect: By Trust)
Holdings
- 104,428(indirect: By Sanderling V Biomedical L.P.)
Common Stock
- 37,594(indirect: By Sanderling V Beteiligungs GmbH & Co. KG)
Common Stock
- 426,330(indirect: By Sanderling Venture Partners V, L.P.)
Common Stock
- 42,250(indirect: By Partnership)
Common Stock
Footnotes (5)
- [F1]On 12/26/06, Kingsbury Capital Partners, L.P. IV commenced a liquidating distribution to its partners of an aggregate of 339,766 shares of common stock of the issuer, 17,725 shares of which were received by the reporting person and 3,398 shares of which were received by the general partner of Kingsbury Capital Partners, L.P. IV, Kingsbury Associates, L.P. In turn, Kingsbury Associates, L.P. distributed the 3,398 shares of common stock of the issuer to its partners, 2,162 of which were received by the reporting person. Accordingly, the reporting person received an aggregate of 19,887 shares pursuant to the distribution.
- [F2]Not applicable.
- [F3]The reporting person is the general partner of Kingsbury Associates, L.P., which is a general partner of Kingsbury Capital Partners, L.P. IV. The reporting person disclaims beneficial ownership of the shares held by Kingsbury Capital Partners, L.P. IV, except to the extent of his pecuniary interests in the named fund. As general partner, the reporting person has voting and investment power with respect to the shares held by Kingsbury Capital Partners, L.P. IV.
- [F4]Includes 112,905 shares previously transferred by the reporting person to By Timothy J. Wollaeger and Cynthia K. Wollaeger, trustees, U/A DTD 4/25/1985.
- [F5]The reporting person is the managing director of Middleton, McNeil & Mills Associates V, LLC, the general partner of Sanderling Venture Partners V, L.P., Sanderling V Biomedical, L.P., Sanderling V Limited Partnership and Sanderling V Beteiligungs GmbH & Co. KG. The reporting person disclaims beneficial ownership of the shares held by Sanderling Venture Partners V, L.P., Sanderling V Biomedical, L.P., Sanderling V Limited Partnership and Sanderling V Beteiligungs GmbH & Co. KG, except to the extent of his pecuniary interests in the named fund. The reporting person shares voting and investment power with respect to the shares held by Sanderling Venture Partners V, L.P., Sanderling V Biomedical, L.P., Sanderling V Limited Partnership and Sanderling V Beteiligungs GmbH & Co. KG with the other managing directors of Middleton, McNeil & Mills Associates V, LLC.
Documents
Issuer
DIGIRAD CORP
CIK 0000707388
Entity typeother
Related Parties
1- filerCIK 0001238948
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 2:40 PM ET
- Size
- 11.9 KB